Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isolagen Therapy for Interdental Papillary Insufficiency
NCT00655889Phase 2Completed
- Sponsor
- Castle Creek Biosciences
- Start
- Jan 2006
- Primary completion
- Apr 2008
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
A Phase 2 trial of azficel-t in interdental papilla deficiency, sponsored by Castle Creek Biosciences. Started Jan 2006; status: completed.
02
Drugs
azficel-t
03
Conditions
interdental papilla deficiency
Beyond the preview
Go deeper on NCT00655889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655889.